{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:04:33Z","timestamp":1761743073950},"reference-count":10,"publisher":"Walter de Gruyter GmbH","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,1,1]]},"DOI":"10.2478\/v10007-007-0049-x","type":"journal-article","created":{"date-parts":[[2008,4,12]],"date-time":"2008-04-12T00:21:24Z","timestamp":1207959684000},"source":"Crossref","is-referenced-by-count":7,"title":["Use of Folin-Ciocalteu phenol reagent and 3-methyl-2-benzothiazolinone hydrazine hydrochloride in the determination of oxcarbazepine in pharmaceuticals"],"prefix":"10.2478","volume":"58","author":[{"given":"Muruganathan","family":"Gandhimathi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thengungal","family":"Ravi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","reference":[{"key":"1","unstructured":"<i>The Merck Index<\/i>, 13<sup>th<\/sup> ed., Merck & Co., Inc., White house Station (NJ) 2001, p. 1240."},{"key":"2","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.phrs.2004.09.008","article-title":"A simple method to monitor plasma concentrations of oxcarbazepine, carbamazepine, their main metabolites and lamotrigine in epileptic patients","volume":"51","author":"L. Franceschi","year":"2005","journal-title":"Pharmacol. Res."},{"key":"3","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jchromb.2005.02.004","article-title":"Determination of oxcarbazepine and its metabolites in postmortem blood and hair by means of liquid chromatography with mass detection (HPLC\/APCI\/MS)","volume":"825","author":"M. Klys","year":"2005","journal-title":"J. Chromatogr. B"},{"key":"4","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.jpba.2006.12.002","article-title":"A validated stability indicating method for oxcarbazepine","volume":"43","author":"D. Pathare","year":"2007","journal-title":"J. Pharm. Biomed. Anal."},{"key":"5","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.jpba.2006.09.029","article-title":"Determination of oxcarbazepine by square wave adsorptive stripping voltammetry in pharmaceutical preparations","volume":"43","author":"M. Calvo","year":"2007","journal-title":"J. Pharm. Biomed. Anal."},{"key":"6","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.jpba.2006.07.047","article-title":"Development and validation of high performance liquid chromatographic method for the determination of oxcarbazepine and its main metabolites in human plasma and cerebrospinal fluid and its application to pharmacokinetic study","volume":"43","author":"V. Kimiskidis","year":"2007","journal-title":"J. Pharm. Biomed. Anal."},{"key":"7","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jchromb.2005.12.003","article-title":"Use of micro bore LC-MS\/MS for the quantitation of oxcarbazepine and its active metabolite in rat brain micro dialysis samples","volume":"831","author":"K. Lanckmans","year":"2006","journal-title":"J. Chromatogr. B."},{"key":"8","doi-asserted-by":"crossref","first-page":"265","DOI":"10.4103\/0250-474X.25734","article-title":"Spectrophotometric method for the estimation of oxcarbazepine in tablets","volume":"68","author":"C. Ramaa","year":"2006","journal-title":"Indian J. Pharm. Sci."},{"key":"9","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0731-7085(02)00602-7","article-title":"LC method for the determination of oxcarbazepine in pharmaceutical preparations","volume":"31","author":"M. Qi","year":"2003","journal-title":"J. Pharm. Anal."},{"key":"10","unstructured":"ICH Harmonized Tripartite Guideline, ICH Topic Q2B, Validation of analytical Procedures: Methodology, ICH, London 1996."}],"container-title":["Acta Pharmaceutica"],"original-title":[],"link":[{"URL":"https:\/\/www.degruyter.com\/view\/j\/acph.2008.58.issue-1\/v10007-007-0049-x\/v10007-007-0049-x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,30]],"date-time":"2020-05-30T18:27:43Z","timestamp":1590863263000},"score":1,"resource":{"primary":{"URL":"https:\/\/content.sciendo.com\/doi\/10.2478\/v10007-007-0049-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1,1]]},"references-count":10,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.2478\/v10007-007-0049-x","relation":{},"ISSN":["1846-9558","1330-0075"],"issn-type":[{"value":"1846-9558","type":"electronic"},{"value":"1330-0075","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1,1]]}}}